A PHASE 2B OPEN‐LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF HBI‐8000 (TUCIDINOSTAT) IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA (PTCL)

Authors :: Kim, W. S.
Rai, S.
Ando, K.
Choi, I.
Izutsu, K.
Tsukamoto, N.
Yokoyama, M.
Tsukasaki, K.
Kuroda, J.
Ando, J.
Hidaka, M.
Koh, Y.
Shibayama, H.
Uchida, T.
Yang, D. H.
Ishitsuka, K.
Ishizawa, K.
Kim, J. S.
Lee, H. G.
Minami, H.
Source :: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p
Publication Year :: 2021

Full Text Access

Tools